Assess the Potential of the IVC Distensibility Index as a Predictor of Postoperative Fluid Status in Children.
NCT ID: NCT06957171
Last Updated: 2025-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2024-04-01
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrafiltration Effect on Extravascular Lung Water in Pediatric Cardiac Surgery
NCT03146143
Inferior Vena Cava Index in Patients Undergoing Liver Resection
NCT02404909
Comparison Between Perfusion Index and Pulse Pressure Variability for Prediction of Intravascular Volume During Major Abdominal Surgeries
NCT07024108
Inferior Vena Cava Collapsibility Index Assessment in Predicting Post Spinal Anaesthesia Hypotension in Patients Undergoing Arthroscopic Knee Surgeries.
NCT06767033
Pre-operative Ultrasonographic Evaluation of Caval Aorta Diameter Index as a Predictor for Post-induction Hypotension
NCT04658576
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Preoperative assessment will be done which includes Medical History and Clinical Examination: Age, gender, and weight will be recorded, Number of fasting hours, Surgical History documentation of previous surgeries, if any, including details on anesthetic techniques. family history of cardiovascular, renal, or fluid balance disorders. Information on any known allergies, particularly to medications, as well as a list of current medications being taken by the patient. Any coexisting medical conditions, particularly autoimmune, inflammatory, or chronic diseases, will be documented (e.g., asthma, diabetes, renal insufficiency).
Specific Examination for IVC Distensibility:
• Ultrasonographic Examination: Preoperative ultrasound will be used to measure the baseline Inferior Vena Cava (IVC) diameter and assess its distensibility as a part of the preoperative evaluation.
Preoperative Assessment of Fluid Balance:
• Laboratory Tests: Baseline blood tests, including complete blood count, serum electrolytes, and renal function tests, will be performed to assess overall fluid and electrolyte balance.
Intraoperative Monitoring:
Intraoperative fluid strategy will be followed with the local protocol 10 ml/kg/h will be given, and additional boluses 10-20 ml/kg if needed (in case of hemodynamic instability, increasing lactate), losses will be compensated with fluid or blood (if exceeded the allowable blood loss).
This fluid regimen is individualized by the attending anaesthesiologist according to the actual requirement, The volume of fluids administered intraoperatively will be meticulously recorded. Urine Output Documentation of baseline urine output as an indicator of renal function and fluid status.
Postoperative Settings:
All ultrasonographic measurments of IVC will be performed at the end of surgery, before extubation (patient is anaesthetized and completely relaxed, in the supine position, PEEP less than 7 cmH2O and tidal volume 6-8 ml/kg The probe will be placed at the sub xiphoid area and measurements will be obtained in M-mode imaging performed 2 to 3 cm distal to the right atrium in the long-axis subcostal view..IVC diameter during inspiration (IVCi) and expiration (IVCe) will be measured, Collapsibility index (CI) measured as difference between IVCe, IVCi divided on IVCe (CI = IVCe - IVCi /IVCe x100).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: Age 1-4 years, Conservative Fluid
Patients aged 1 to 4 years receiving intraoperative fluid \<10 ml/kg/h.
No interventions assigned to this group
Group 2: Age 1-4 years, Liberal Fluid
Patients aged 1 to 4 years receiving intraoperative fluid ≥10 ml/kg/h.
No interventions assigned to this group
Group 3: Age 4-8 years, Conservative Fluid
Patients aged 4 to 8 years receiving intraoperative fluid \<10 ml/kg/h.
No interventions assigned to this group
Group 4: Age 4-8 years, Liberal Fluid
Patients aged 4 to 8 years receiving intraoperative fluid ≥10 ml/kg/h.
No interventions assigned to this group
Group 5: Age 8-12 years, Conservative Fluid
Patients aged 8 to 12 years receiving intraoperative fluid \<10 ml/kg/h.
No interventions assigned to this group
Group 6: Age 8-12 years, Liberal Fluid
Patients aged 8 to 12 years receiving intraoperative fluid ≥10 ml/kg/h.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA status I - II
* Patients undergoing elective surgical procedures requiring general anesthesia.
Exclusion Criteria
* Renal disorders (Acute or Chronic).
* PEEP more than 7 cmH2O at time of assessment of IVC distensibility index
1 Year
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rawan Abu Deif, M.B.B.CH
Role: PRINCIPAL_INVESTIGATOR
Anaesthesia resident Ain Shams University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University
Cairo, Egypt, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMASU MS 728/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.